Altimmune (ALT) Retained Earnings (2010 - 2026)
Altimmune (ALT) reported Retained Earnings of -$5.2 million for Q1 2026, down 4.42% year-over-year from -$5.5 million in Q1 2025, and down 6.01% quarter-over-quarter from -$4.9 million in Q4 2025.
Altimmune (ALT) Retained Earnings (2010 - 2026) Analysis & Trends
Altimmune (ALT) has 17 years of Retained Earnings data on file, last reported at -$5.2 million in Q1 2026.
- Retained Earnings for Q1 2026 came in at -$5.2 million, down 4.42% year-over-year; the trailing twelve-month figure through Mar 2026 was -$5.2 million (down 4.42% YoY), and the FY2025 annual result was -$4.9 million, up 0.9% from the prior year.
- Retained Earnings retreated to -$5.2 million in Q1 2026 per ALT's latest filing, from -$4.9 million in the prior quarter.
- Over five years, Retained Earnings peaked at -$4.8 million in Q3 2024 and troughed at -$515.4 million in Q2 2024.
- A 5-year average of -$150.3 million and a median of -$5.2 million in 2026 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2024 and 2025: Retained Earnings plunged 9520.17% in 2024, then surged 99.02% in 2025.
- A 5-year view of Retained Earnings shows it stood at -$5.2 million in 2022, then grew by 4.27% to -$5.0 million in 2023, then climbed by 0.62% to -$5.0 million in 2024, then rose by 0.9% to -$4.9 million in 2025, then dropped by 6.01% to -$5.2 million in 2026.
- Business Quant data shows ALT's Retained Earnings at -$5.2 million in Q1 2026, -$4.9 million in Q4 2025, and -$5.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Altimmune | 336.67 Mn | 336.67 Mn | - | -5.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.22 Mn |
| Dec 31, 2025 | -4.93 Mn |
| Sep 30, 2025 | -5.02 Mn |
| Jun 30, 2025 | -5.04 Mn |
| Mar 31, 2025 | -5.00 Mn |
| Dec 31, 2024 | -4.97 Mn |
| Sep 30, 2024 | -4.85 Mn |
| Jun 30, 2024 | -515.37 Mn |
| Mar 31, 2024 | -490.73 Mn |
| Dec 31, 2023 | -5.00 Mn |
| Sep 30, 2023 | -434.69 Mn |
| Jun 30, 2023 | -414.02 Mn |
| Mar 31, 2023 | -5.10 Mn |
| Dec 31, 2022 | -5.23 Mn |
| Sep 30, 2022 | -5.30 Mn |
| Jun 30, 2022 | -332.71 Mn |
| Mar 31, 2022 | -312.60 Mn |
| Dec 31, 2021 | -293.17 Mn |
| Sep 30, 2021 | -5.04 Mn |
| Jun 30, 2021 | -235.77 Mn |